Drug conversion device
Latest Elan Corporation, plc Patents:
- Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds
- Nanoparticulate and controlled release compositions comprising nilvadipine
- NANOPARTICULATE FORMULATIONS OF MODAFINIL
- Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
- COMBINATION OF A NARCOTIC AND NON-NARCOTIC ANALGESIC
Description
FIG. 1 is a perspective view of our new drug conversion device;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a right side view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a top view thereof; and,
FIG. 7 is a bottom view thereof.
Claims
The ornamental design for a drug conversion device, as shown.
Referenced Cited
Patent History
Patent number: D437930
Type: Grant
Filed: May 13, 1999
Date of Patent: Feb 20, 2001
Assignee: Elan Corporation, plc (Dublin)
Inventors: Joseph Gross (Moshav Mazor), Gilad Lavi (Holon), Izrail Tsals (Sudbury, MA), Gil Yigal (Gan-Yavne)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Kathleen Maher Lynch
Application Number: 29/104,854
Type: Grant
Filed: May 13, 1999
Date of Patent: Feb 20, 2001
Assignee: Elan Corporation, plc (Dublin)
Inventors: Joseph Gross (Moshav Mazor), Gilad Lavi (Holon), Izrail Tsals (Sudbury, MA), Gil Yigal (Gan-Yavne)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Kathleen Maher Lynch
Application Number: 29/104,854
Classifications
Current U.S. Class:
Article For The Introduction, Removal Or Collection Of Fluids (e.g., Infusion, Extraction, Irrigation, Etc.) (3) (D24/108);
Hand Manipulated Tool Or Instrument (23) (D24/133)
International Classification: 2401;
International Classification: 2401;